One-hour post-load plasma glucose level during the OGTT predicts dysglycemia: Observations from the 25 year follow-up of the Israel Study of Glucose Intolerance, Obesity and Hypertension

Diabetes Research and Clinical Practice

Volumn 120, Issue , 2016, Pages 221-228

  Bergman, Michael ^a   Chetrit, Angela ^b   Roth, Jesse ^c   Jagannathan, Ram ^a   Sevick, Mary ^a   Dankner, Rachel ^b,c,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Diabetes; Dysglycemia; OGTT; Prediabetes; Prevention

Indexed keywords

GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; AGE; ARTICLE; BIOCHEMICAL ANALYSIS; BLOOD PRESSURE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; DISEASE COURSE; DYSGLYCEMIA; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INTERVIEW; ISRAEL; LIFESTYLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OBESITY; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL PARAMETERS; PREDICTION; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SEX; SMOKING; SURVIVOR; AGED; BLOOD; GLUCOSE TOLERANCE TEST; MIDDLE AGED; RISK;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; INSULIN; ISRAEL; MALE; MIDDLE AGED; OBESITY; PREDIABETIC STATE; RISK;

EID: 84985960735     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2016.08.013     Document Type: Article

References (35)

1. [1] Ramachandran, A., Snehalatha, C., Diabetes prevention programs. Med Clin North Am 95 (2011), 353–372.
2. [2] Gerstein, H.C., Santaguida, P., Raina, P., Morrison, K.M., Balion, C., Hunt, D., et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78 (2007), 305–312.
3. [3] Alberti, K.G., Zimmet, P.Z., Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998), 539–553.
4. [4] Jagannathan, R., Sevick, M.A., Fink, D., Dankner, R., Chetrit, A., Roth, J., et al. The 1-hour post-load glucose level is more effective than HbA1c for screening dysglycemia. Acta Diabetol 53 (2016), 543–550.
5. [5] Chamukuttan, S., Ram, J., Nanditha, A., Shetty, A.S., Sevick, M.A., Bergman, M., et al. Baseline level of 30 min plasma glucose is an independent predictor of incident diabetes among Asian Indians: analysis of two diabetes prevention programmes. Diabetes Metab Res Rev, 2016, 10.1002/dmrr.2799.
6. [6] Jagannathan, R., Sevick, M.A., Li, H., Fink, D., Dankner, R., Chetrit, A., et al. Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function, and insulin sensitivity: a pilot study from a real world health care setting. Endocrine 52 (2016), 172–175.
7. [7] Bergman, M., Chetrit, A., Roth, J., Dankner, R., One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel Study of Glucose Intolerance, Obesity and Hypertension. Diabet Med 33 (2016), 1060–1066.
8. [8] Cubeddu, L.X., Hoffmann, I.S., One-hour postload plasma glucose levels, a predictor of additional risk for diabetes: prevalence, mechanisms, and associated cardiovascular and metabolic risk factors in Hispanics. Metab Syndr Relat Disord 8 (2010), 395–402.
9. [9] Succurro, E., Arturi, F., Lugara, M., Grembiale, A., Fiorentino, T.V., Caruso, V., et al. One-hour postload plasma glucose levels are associated with kidney dysfunction. Clin J Am Soc Nephrol 5 (2010), 1922–1927.
10. [10] Alyass, A., Almgren, P., Akerlund, M., Dushoff, J., Isomaa, B., Nilsson, P., et al. Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts. Diabetologia 58 (2015), 87–97.
11. [11] Bergman, M., Chetrit, A., Roth, J., Dankner, R., Dysglycemia and long-term mortality: observations from the Israel Study of Glucose Intolerance, Obesity and Hypertension. Diabetes Metab Res Rev 31 (2015), 368–375.
12. [12] Modan, M., Halkin, H., Karasik, A., Lusky, A., Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance. Am J Epidemiol 119 (1984), 431–444.
13. [13] Modan, M., Karasik, A., Halkin, H., Fuchs, Z., Lusky, A., Shitrit, A., et al. Effect of past and concurrent body mass index on prevalence of glucose intolerance and type 2 (non-insulin-dependent) diabetes and on insulin response. The Israel Study of Glucose Intolerance, Obesity and Hypertension. Diabetologia 29 (1986), 82–89.
14. [14] Modan, M., Halkin, H., Fuchs, Z., Lusky, A., Chetrit, A., Segal, P., et al. Hyperinsulinemia–a link between glucose intolerance, obesity, hypertension, dyslipoproteinemia, elevated serum uric acid and internal cation imbalance. Diabetes Metab 13 (1987), 375–380.
15. [15] Group NDD. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28 (1979), 1039–1057.
16. [16] Cerasi, E., Ependic, S., Luft, R., Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects. Lancet 1 (1973), 794–797.
17. [17] Laboratory Methods Committee, Lipid Research Clinics Program: manual of Laboratory Operations, Vol 1. Lipid and Lipoprotein Analysis. Washington, DC, US Government Printing Office, DHEW Publication No. (NIH) 75–628, 1974.
18. [18] Buysschaert, M., Medina, J.L., Bergman, M., Shah, A., Lonier, J., Prediabetes and associated disorders. Endocrine 48 (2015), 371–393.
19. [19] Bianchi, C., Miccoli, R., Trombetta, M., Giorgino, F., Frontoni, S., Faloia, E., et al. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired beta-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study. J Clin Endocrinol Metab 98 (2013), 2100–2105.
20. [20] Bergman, M., Dankner, R., Roth, J., Narayan, K.M., Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches. Endocrine 44 (2013), 66–69.
21. [21] Abdul-Ghani, M.A., Lyssenko, V., Tuomi, T., DeFronzo, R.A., Groop, L., Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 32 (2009), 281–286.
22. [22] Abdul-Ghani, M.A., Williams, K., DeFronzo, R.A., Stern, M., What is the best predictor of future type 2 diabetes?. Diabetes Care 30 (2007), 1544–1548.
23. [23] Priya, M., Anjana, R.M., Chiwanga, F.S., Gokulakrishnan, K., Deepa, M., Mohan, V., 1-hour venous plasma glucose and incident prediabetes and diabetes in Asian indians. Diabetes Technol Ther 15 (2013), 497–502.
24. [24] Oka, R., Aizawa, T., Miyamoto, S., Yoneda, T., Yamagishi, M., One-hour plasma glucose as a predictor of the development of Type 2 diabetes in Japanese adults. Diabet Med, 2015, 10.1111/dme.12994.
25. [25] Dankner, R., Abdul-Ghani, M.A., Gerber, Y., Chetrit, A., Wainstein, J., Raz, I., Predicting the 20-year diabetes incidence rate. Diabetes Metab Res Rev 23 (2007), 551–558.
26. [26] Abdul-Ghani, M.A., Abdul-Ghani, T., Ali, N., Defronzo, R.A., One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 31 (2008), 1650–1655.
27. [27] Manco, M., Panunzi, S., Macfarlane, D.P., Golay, A., Melander, O., Konrad, T., et al. One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study. Diabetes Care 33 (2010), 2090–2097.
28. [28] Sciacqua, A., Maio, R., Miceli, S., Pascale, A., Carullo, G., Grillo, N., et al. Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension. PLoS One, 7, 2012, e44470.
29. [29] Sciacqua, A., Miceli, S., Carullo, G., Greco, L., Succurro, E., Arturi, F., et al. One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care 34 (2011), 1406–1411.
30. [30] Temelkova-Kurktschiev, T.S., Koehler, C., Henkel, E., Leonhardt, W., Fuecker, K., Hanefeld, M., Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 23 (2000), 1830–1834.
31. [31] Perreault, L., Kahn, S.E., Christophi, C.A., Knowler, W.C., Hamman, R.F., Diabetes Prevention Program Research G. Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care 32 (2009), 1583–1588.
32. [32] Perreault, L., Pan, Q., Mather, K.J., Watson, K.E., Hamman, R.F., Kahn, S.E., et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 379 (2012), 2243–2251.
33. [33] Diabetes Prevention Program Research G. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 3 (2015), 866–875.
34. [34] Knowler, W.C., Barrett-Connor, E., Fowler, S.E., Hamman, R.F., Lachin, J.M., Walker, E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002), 393–403.
35. [35] Clarke, R., Shipley, M., Lewington, S., Youngman, L., Collins, R., Marmot, M., et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 150 (1999), 341–353.